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ABSTRACT
Objectives: To determine if  there is a release of IL-6 after surgical removal of lower third molars and to compare the 
amount of IL-6 in patients treated with NSAID and in those treated with glucocorticoids.
Study Design: Prospective study on 73 patients who attended the Oral Surgery Unit (Department of Medicine and Oral 
Surgery) in the Faculty of Odontology of the Universidad Complutense de Madrid for the surgical removal of their 
lower third molars. These patients were separated into two groups: the diclofenac group and the methylprednisolone 
group. A record card was completed with preoperative and postoperative epidemiological and clinic data. Samples of 
gingival crevicular fluid were collected in order to assess the release of interleukin-6 after surgery. In order to make a 
broad study of data, the BMDP program was used for statistical analysis.
Results: Levels of IL-6 were higher after surgical extraction of lower third molars and remained high until the seventh 
day after. Levels were higher in the diclofenac group 24 hours after surgery, the difference was significant (0.008).
Conclusions: IL-6 is higher after surgical extraction of lower third molars, behaving differently in each of the groups. 
Key words: Third molar surgery, cytokines, interleukin-6, methylprednisolone, diclofenac.
RESUMEN
Objetivos: Determinar si tras la cirugía del tercer molar inferior se produce una liberación de interleuquina-6 (IL-6) y 
comparar la cantidad de IL-6 en pacientes que tomaron AINES y en aquellos que tomaron glucocorticoides.
Diseño del estudio: Estudio prospectivo sobre 73 pacientes sometidos a la extracción quirúrgica de los terceros molares 
inferiores. Fueron divididos en dos grupos: De diclofenaco y de metilprednisolona. Se recogieron muestras de fluído 
crevicular gingival para valorar la liberación de interleuquina-6 tras la cirugía. Se usó el programa estadístico BMDP 
para hacer un amplio tratamiento de los datos.
Resultados: Los niveles de IL-6 se elevaron tras la cirugía del tercer molar inferior permaneciendo elevados al séptimo 
día del postoperatorio, elevándose más a las 24 horas en el grupo de diclofenaco siendo esta diferencia significativa 
(0,008).
Conclusiones: La IL-6 se eleva tras la cirugía del tercer molar inferior, presentando diferente comportamiento en los 
dos grupos de estudio. 
Palabras clave: Cirugía del tercer molar, citoquinas, interleuquina-6, metilprednisolona, diclofenaco.
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INTRODUCTION
In the last few years, a lot of research has been carried out 
on the utility of  certain cytokines, such as interleukin-1 
and interleukin-6, as activity markers in periodontitis. 
However, to our knowledge, no study has been published 
on the utility of these substances in the surgical extraction 
of lower third molars (1,2). IL-6 plays an important role in 
inflammation, together with IL-1 and the Tumor Necrosis 
Factor (TNF). 
In the maxillofacial area, Miyawaki et al. (3) have proved 
that the level of  IL-6 in plasma increases after different 
operations (cystectomy, benign tumor extirpation, etc.) and 
therefore, we assume that a large amount of cytokines (IL-
6 among them) are released locally after surgical removal 
of lower third molars, and that to a great extent these are 
responsible for postoperative complications.
Cruickshank et al. (4) studied the response of IL-6 in patients 
who had undergone different types of operations (minor 
surgery, cholecystectomy, hip surgery, colorectal surgery 
and major vascular surgery), finding that levels of IL-6 were 
related to the duration of surgery. The authors concluded that 
IL-6 is a sensitive and early marker of tissue damage.
The concentration of IL-6 may also change depending on 
the antiinflammatory used during the postoperative period, 
since there are studies which demonstrate that glucocorti-
coids inhibit the production of this cytokine (5).
The objectives of this study were to determine if  there is a 
release of IL-6 after surgical removal of lower third molars 
and to compare the amount of IL-6 in patients treated with 
NSAID and in those treated with glucocorticoids.
PATIENTS AND METHOD
The study was carried out on 73 patients who attended 
the Oral Surgery Unit (Department of Medicine and Oral 
Surgery) in the Faculty of Odontology of the Universidad 
Complutense de Madrid for the surgical removal of their 
lower third molars. As laboratory material we used paper 
points (Periopaper strip®. Proflow Incorporated. New York. 
USA), Periotron® 6000 (Proflow Incorporated. New York. 
USA), tubes (Microspin filters®-Teknocroma-) and IL-6 
kit (ICN Pharmaceuticals, Inc. California). The following 
equipment was used: a freezer to maintain the samples at 
–80ºC, microsyringe (Hamilton Bonaduz A. G. Switzer-
land), micropipettes, cup vibrator (IKA-Works Inc. ®USA) 
with speeds between 200-2500/min, automatic washer (Easy 
washer EAW 8/12®), reader (Easy reader EAR 400®) and 
printer and centrifuge. (Selecta®).
Inclusion criteria were as follows: Patients over 18 whose 
lower third molars required extraction. Informed consent to 
participate in the study was signed. Without systemic patho-
logy and without clinical symptoms in the third molar.
Exclusion criteria were: patients with systemic pathology, 
pregnant or breast-feeding women, or patients with sympto-
mology in the third molar or who had taken anti-inflam-
matories within the previous 7 days.
Two groups were formed at random: in group A, 36 patients 
took oral diclofenac sodium (Voltaren®) at doses of 50 mg 
every 8 hours for the first three days after surgery; and in group 
B, 37 patients took oral methylprednisolone (Urbason®) at 
doses of 4 mg every 8 hours also for three days. All patients 
received antibiotic treatment with oral amoxicillin at doses of 
750 mg every 8 hours during 7 days after surgery. Those who 
were still in pain were able to request the oral administration 
of a rescue drug, magnesium metamizol (Nolotil®), at doses 
of 575 mg every 6 or 8 hours for pain relief. 
Sterile paper points (Periopaper Strip®) were used to collect 
five samples of gingival crevicular fluid (GCF) from each 
of the patients. One first preoperative sample was collected 
immediately before local anesthesia (A). The samples were 
taken from the periodontal pocket in cases where this partia-
lly perforated the retromolar trigone mucosa, and from the 
crevicular sulcus of the distal face of the second definitive 
molar in cases where the third molar was not visible. The 
other samples were collected immediately after surgery (B), 
one hour after surgery (C), 24 hours after surgery (D) and 
seven days after surgery when removing the sutures (E), all 
from the same location as the preoperative sample. 
Samples were collected as follows: vacuum drying, isolation 
of the area with cotton rolls, mild air drying of the lower 
second or third molar, and placing the periopaper in the 
crevicular sulcus to obtain the sample of crevicular fluid or 
blood. This paper point has to be maintained in the above 
mentioned position for 30 seconds for crevicular fluid co-
llection and 15 seconds for blood collection. Samples are 
then placed between the Periotron sensors to measure the 
amount of crevicular fluid obtained. The Periotron was 
previously calibrated to obtain microliters.  Samples were 
put into a vial with a filter and this vial was preserved in 
dry ice until freezing at –80ºC.
In the laboratory, samples were treated using the ELISA 
assay, which is a “sandwich” enzyme immunoassay. The 
samples and the standards are incubated in microtiter we-
lls, covered with a monoclonal anti-IL-6 antibody and in 
the presence of a second monoclonal anti-IL-6 antibody 
together with acetylcholinesterase. After incubation, the 
wells are washed and enzyme activity is measured with 
a chromogenic substrate. The intensity of  the colour is 
proportional to the concentration of IL-6 in the sample or 
the standard.
In order to completely separate the sample and the Pe-
riopaper®, GCF was diluted from the paper points using 
filtration and centrifugation with buffer aliquots (50 mM 
phosphate buffer, pH 7.2). To summarize, 200 µl of the pre-
viously mentioned buffer were applied to each paper point 
and the tube was centrifuged at 8000 rpm for 10 minutes. 
Reagents were prepared in the following manner:
The lyophilized IL-6 conjugate was reconstituted with the 
amount of distilled water as stated on the label of the vial, 
that is, 12 ml.
Diluent 2 was reconstituted with 6 ml of distilled water.
The wash solution was diluted with 950 ml of  distilled 
water.
The lyophilized IL-6 standard was reconstituted with 0.5 
ml of distilled water, obtaining 10 ng/ml.
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The control serum was reconstituted with 1 ml of distilled 
water.
A standard curve was prepared before starting each assay. 
Once the standard curve was obtained, the assay carried out 
with the samples of gingival crevicular fluid in accordance 
with the established assay protocol. The results of the sam-
ples were calculated by interpolation of the standard curve 
prepared in the same assay as the samples. The results were 
expressed in log 10. 
The statistical evaluation was made at the Data Processing 
Center of the Universidad Complutense de Madrid. The 
BMDP program was used to produce a detailed description 
of data, frequencies tables, bivariate graphics, t-Tests and 
repeated measures analysis of variance. For quantitative or 
continuous variables, Student’s t-Test (parametric test for 
comparing means) and the Mann-Whitney test (non-para-
metric test) were used. Chi-square test and Yates’ correction 
were used for qualitative or categorical variables. 
RESULTS
The samples were homogeneous for age, sex, side, position 
of the third molar and length of operation.
The mean age in the methylprednisolone group  was 23.4 
years and in the diclofenac group  was 23.6, with no signi-
ficant difference between them (Student’s t = 0.866; Mann-
Whitney = 0.665).
With respect to sex, in the methylprednisolone group 73% 
were female against 27% male, and in the diclofenac group 
52.8% were women and 47.2% men. The Chi-square test 
(P=0.07) and the Yachts correction (P=0.122) were used 
to determine the randomness of the sample, the variables 
being either qualitative or categorical, and demonstrating 
that the differences were not significant.
Regarding the side of surgery, in the methylprednisolone 
group   this was the right-hand side in 56.8% of cases and 
the left-hand side in 43.2%. In the diclofenac group  this 
was evenly distributed at 50% each, that is to say, there were 
no significant differences in the side operated on: Pearson’s 
chi-square P=0.562 and Yachts correction P=0.730.
Regarding the position of the third molar, four positions 
were considered in relation to the axial axis of the second 
molar: Distal, vertical, mesial and horizontal. There were no 
significant differences in position (P=0.633), consequently 
this did not influence the results.
Lastly, the duration of  the operation was measured in 
both groups in minutes from the beginning of the incision 
until the completion of the suture. The mean time in the 
methylprednisolone group was 11.4 minutes and the diclo-
fenac group 10.9 minutes, the Student t-Test was 0.709 and 
the Mann-Whitney test 0.499; thus, this difference was not 
significant either.
Table 1. Concentration of IL-6 at the different measurements.
MEASUREMENTS
A = preoperative, B = immediate postoperative, C = at one hour, D = at 24 hours, E = at 7 days
A B C D E 
MEAN 3.5601 3.2710 3.3724 3.8994 4.0720 
DEV. EST. 0.4241 0.3177 0.2606 0.5313 0.4434 
ERR. EST. 0.0717 0.0522 0.0461 0.0873 0.0739 
SIZE 35 37 32 37 36 
MAXIMUM 4.3704 4.1646 3.9437 4.9190 5.0681 
METHYLPRED.
GROUP
MINIMUM 2.8125 2.5662 2.7740 2.7647 3.4090 
MEAN 3.3849 3.3498 3.4691 4.1988 3.7731 
DEV. EST. 0.2921 0.2779 0.2486 0.4039 0.4664 
ERR. EST. 0.0494 0.0463 0.0414 0.0673 0.0777 
SIZE 35 36 36 36 36 
MAXIMUM 4.2090 3.8676 4.1291 4.8432 4.6240 
DICLOFENAC 
GROUP
MINIMUM 2.9018 2.3861 3.0221 3.2974 2.8768 









A vs B (NOT SIG.) -0.0479 0.2843 0.6164 
A vs C (NOT SIG.) -0.1224 0.2097 0.5419 
A vs D (SIG.) -0.6609 -0.3287 0.0034 
A vs E (SIG.) -0.8288 -0.4967 -0.1645 
B vs C (NOT SIG.) -0.4067 -0.0745 0.2576 
B vs D (SIG.) -0.9451 -0.6130 -0.2808 
B vs E (SIG.) -1.1131 -0.7810 -0.4488 
C vs D (SIG.) -0.8706 -0.5385 -0.2063 
C vs E (SIG.) -1.0386 -0.7064 -0.3743 
D vs E (NOT SIG.) -0.5001 -0.1680 0.1642 
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A vs B (NOT SIG.) -0.1769 0.0499 0.2768 
A vs C (NOT SIG.) -0.2994 -0.0726 0.1543 
A vs D (SIG.) -1.0396 -0.8127 -0.5858 
A vs E (SIG.) -0.6105 -0.3837 -0.1568 
B vs C (NOT SIG.) -0.3494 -0.1225 0.1044 
B vs D (SIG.) -1.0895 -0.8626 -0.6358 
B vs E (SIG.) -0.6605 -0.4336 -0.2068 
C vs D (SIG.) -0.9670 -0.7401 -0.5133 
C vs E (SIG.) -0.5380 -0.3111 -0.0842 
D vs E (SIG.) 0.2022 0.4290 0.6559 
Table 2. Multiple comparisons test in the methylprednisolone group. Table 3. Multiple comparisons test in the diclofenac group.
Fig. 1. Concentration of IL-6. Repeated measures analysis of variance.
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The behavior of  the cytokine throughout the study was 
analyzed in both groups by descriptive statistics. Although 
we studied both the amount and the concentration of 
IL-6, for brevity we use the term concentration of IL-6, 
which is the amount of IL-6 divided by the total amount of 
gingival crevicular fluid. In table 1 we can see the behavior 
at each moment. The difference was significant 24 hours 
after surgery, when the concentration was higher in the 
diclofenac group (p<0.01), and 7 days after surgery, when a 
higher point was reached in the methylprednisolone group 
(p<0.01).
Table 2 shows the multiple comparisons test in the me-
thylprednisolone group, in this case there were significant 
differences between the preoperative concentrations and 
those at 24 hours and 7 days; the preoperative, operative, and 
immediate postoperative concentrations being very similar. 
Likewise, the immediate postoperative, the 24 hour and 7 
day differences are significant, as well as between those at 
one hour after the intervention and those at 24 hours and 
7 days; there being no significant difference between the 
24 hour and the 7 day measurements. Table 3 shows the 
diclofenac group (the only difference with the group that 
took glucocorticoids is that there was a significant difference 
between the 24 hour and the 7 day concentrations). 
In figure 1, we can see the results obtained by the repeated 
measures analysis of variance. There were no significant 
differences between groups (p=0.530), but there were in 
the time effect (p=0) and the interaction effect (p=0.001), 
observing in figure 1 that the two lines are not at all parallel, 
in fact crossing on occasions.
DISCUSSION
In the present study we have attempted to determine the 
presence of IL-6 after surgical extraction of lower third 
molars and the influence of the antiinflammatory used on 
the release of this cytokine.
In relation to the results obtained in both groups, both for 
clinical and laboratory variables, it is important to highlight 
that all samples were homogeneous in age, sex, side of sur-
gery, location and position of the lower third molar, duration 
of surgery, and preoperative amount of IL-6 (although not 
concentration), so that any differences in postoperative 
results cannot be the result of  the characteristics of  the 
patient before surgery, nor to the surgical process itself, 
which was done in a regulated manner and always by the 
same surgeon. In fact, as inferred from Holland’s studies (6), 
technical variations diminish if  the surgery is always done 
by the same surgeon. The only significant difference during 
the preoperative period was that patients in the corticoid 
group showed a higher concentration of IL-6 than patients 
in the NSAID group. This difference was resolved with the 
repeated measures analysis of variance.
The amount and concentration of IL-6 was analyzed and 
significant differences were found  24 hours after surgery, 
when patients in the diclofenac group showed a higher 
amount and concentration of IL-6 (p<0.01), and 7 days after 
surgery, when this higher amount and concentration of IL-6 
was found in the methylprednisolone group (p<0.01).
We are not certain why there is less IL-6 in the methylpred-
nisolone group 24 hours after surgery. It may be due to the 
fact that corticoids inhibit IL-6 more than NSAID.
With the repeated measures analysis of variance we found 
that there were no significant differences in the amount and 
the concentration of IL-6 between groups. However, the 
effect over time was highly significant, that is, the differences 
between the five sample collection times when considering 
both groups together. The interaction effect was also signi-
ficant, that is, each group behaved differently over time.
Several authors have found a correlation between the in-
crease in IL-6 and postoperative complications, such as 
infections (7,8). The surgical trauma alone is enough for 
IL-6 release, while endotoxemia could be an additional 
stimulus for IL-6 concentration (9). We cannot corroborate 
the correlation between IL-6 and infection because there was 
no case of postoperative superinfection in our study. 
According to Tonnesen (10), the routine measurement of IL-
6 acts as a parameter for the identification of patients who 
may develop postoperative complications and will therefore 
require more careful postoperative monitoring. In other 
words, the association of a large increase in postoperative 
levels of IL-6 in plasma with postoperative complications 
may have  prognostic significance (11).
In these patients with complications, the concentration of 
IL-6 is not only higher, but is also present for longer. The 
detection of an extended presence of IL-6 indicates that this 
is actively released for several days, because it has a short 
half-life. Di Padova(12) detected IL-6 one hour after starting 
the operation (cholecystectomy), remaining significantly 
high 72 hours later. We have found a high level of IL-6 even 
7 days after surgery, when there is still some inflammation 
in the body. 
While we have detected IL-6 after surgical extraction of 
lower third molars, other authors have done so in burn 
lesions or after elective surgery (13, 14). Given that IL-6 is 
a mediator of the acute stage reaction in human beings (4), 
it is reasonable to believe that an increase in IL-6 levels in 
serum after surgery is related to the degree of tissue damage. 
This has been demonstrated in several studies on operated 
patients, IL-6 being an early and sensitive marker of sur-
gical damage. In general, the greater the surgical damage, 
the stronger the IL-6 response in serum and the higher the 
concentration (15).
The high increase of IL-6 24 hours after lower third molar 
surgery indicates that this procedure involves significant 
surgical trauma.
Since this cytokine is one of the most important ones invol-
ved in the physiological response to trauma, inflammation 
and infection, a great investigative effort is being made in 
order to find methods to regulate the systemic effects of 
IL-6 and improve postoperative control. Glucocorticoids 
have already been tested in experimental and clinical stu-
dies. The endogenous and exogenous increase in the levels 
of glucocorticoids in blood, diminishes the production of 
IL-6 in human and animal studies (16). 
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Several researchers have obtained satisfactory results using 
glucocorticoids and NSAID for the inhibition of IL-6. Teoh 
(17), for example, detected a lower concentration of IL-6 
in patients who received 250 mg i.v. of methylprednisolone 
after heart bypass surgery. Also in bypass surgery, Engelman 
(18) observed a decrease in IL-6 in patients treated with one 
gram of methylprednisolone before surgery and 4 mg of 
dexamethasone every 6 hours after, these patients leaving 
the ICU one day earlier than usual. Osaka (19) reached 
the same conclusions in neurosurgery, having lower levels 
of IL-6 and a better postoperative in patients treated with 
glucocorticoids.
We must bear in mind the difference between the doses of 
corticoids administered in the previous examples and those 
administered in our study (only 12 mg/day), which explains 
why the results of our study are not as striking as in the 
above examples.
In addition to trying to regulate the production of IL-6 with 
corticoids, other preparations with fewer side-effects are 
being studied, such as ibuprofen and other NSAID (20).
We have only made reference to general surgery because 
very few studies exist on the relationship of IL-6 with Oral 
Surgery. We have found no study on IL-6 and surgery of 
the lower third molar. IL-6 has been related with the patho-
genesis of temporomandibular disorders (inducing osseous 
changes in the condyle) (21,22).
Only one group of  researchers has found a relationship 
between IL-6 and oral and maxillofacial surgery (but not 
specifically with lower third molar surgery). These are Mi-
yawaki et al. (3, 23) who found a relationship between IL-6 
and cystectomy, benign tumor extirpation, radical surgery 
for cancer of the tongue, palate, mandible and  floor of 
the mouth, as well as bone grafts. They also found a rela-
tionship between the increase in IL-6 and the presence of 
postoperative fever, as well as with the duration of surgery 
(although the average duration of these radical interventions 
was 9 hours). These authors state that contamination by oral 
bacteria has an influence on IL-6 release when comparing 
maxillofacial surgery with abdominal surgery,.
After seeing so many and varied studies, we can conclude 
that much research remains to be carried out in order to 
determine whether IL-6 concentration in serum simply 
reflects the level of tissue damage or plays a more active 
role in the host defense mechanism or in the induction of 
postoperative complications.
CONCLUSIONS
1.- After surgical extraction of lower third molars there 
was a significant increase in IL-6 levels in both groups, 
which was evident 24 hours after surgery, remaining high 
after 7 days.
2.- Patients treated with NSAID showed a higher amount 
of IL-6 during the first day with a decrease at the following 
control.
3.- In contrast to the above results, patients treated with 
methylprednisolone showed the highest levels of IL-6 after 
7 days.
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